Lumbrokinase

lumbrokinase · Icahn School of Medicine at Mount Sinai

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lumbrokinase, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome [Phase 1, Phase 2]

See pricing